Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I D Walker

Showing results (101-110 of 194) with videos related to

Pageof 20
Sort By:
Thrombosis and Haemostasis|February 28, 1986
Triton X-114 phase separation of platelet membrane glycoproteins from normal subjects and a patient with type I thrombastheniaU Khanduri, S Clark, I D Walker, et al.
Thrombosis and Haemostasis|June 24, 1985
The effect of the synthetic steroid Org OD14 on fibrinolysis and blood lipids in postmenopausal womenI D Walker, J F Davidson, A Richards, et al.
Internal Medicine Journal|January 7, 2003
Treatment of acquired haemophiliaA C Dykes, I D Walker, G D O Lowe, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|September 24, 1999
Effect of ketorolac and low-molecular-weight heparin individually and in combination on haemostasisI A Greer, J L Gibson, A Young, et al.
Thrombosis and Haemostasis|September 1, 1996
Two recombinant tissue factor reagents compared to conventional thromboplastins for determination of international normalised ratio: a thirty-three-laboratory collaborative study. The Steering Committee of the UK National External Quality Assessment Scheme for Blood CoagulationS Kitchen, I Jennings, T A Woods, et al.
Clinical and Laboratory Haematology|January 1, 1986
Co-incidental Von Willebrands disease and immune thrombocytopenia in pregnancy: treatment with high dose intravenous immunoglobulinD Maharaj, I D Walker, H P McEwan, et al.
The Journal of Biological Chemistry|May 25, 1987
Lethal perinatal osteogenesis imperfecta due to the substitution of arginine for glycine at residue 391 of the alpha 1(I) chain of type I collagenJ F Bateman, D Chan, I D Walker, et al.
British Journal of Haematology|February 26, 2000
Prevalence of the post-thrombotic syndrome in young women with previous venous thromboembolismM D McColl, J Ellison, I A Greer, et al.
The Journal of Thoracic and Cardiovascular Surgery|October 1, 1982
Prostacyclin in cardiopulmonary bypass operationsA Faichney, K G Davidson, D J Wheatley, et al.
British Journal of Haematology|June 1, 1993
Reduced coagulation activation following infusion of a highly purified factor IX concentrate compared to a prothrombin complex concentrateK K Hampton, F E Preston, G D Lowe, et al.
Pageof 20

Showing results (101-110 of 194) with videos related to

Sort By:
Pageof 20
Thrombosis and Haemostasis|February 28, 1986
Triton X-114 phase separation of platelet membrane glycoproteins from normal subjects and a patient with type I thrombastheniaU Khanduri, S Clark, I D Walker, et al.
Thrombosis and Haemostasis|June 24, 1985
The effect of the synthetic steroid Org OD14 on fibrinolysis and blood lipids in postmenopausal womenI D Walker, J F Davidson, A Richards, et al.
Internal Medicine Journal|January 7, 2003
Treatment of acquired haemophiliaA C Dykes, I D Walker, G D O Lowe, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|September 24, 1999
Effect of ketorolac and low-molecular-weight heparin individually and in combination on haemostasisI A Greer, J L Gibson, A Young, et al.
Thrombosis and Haemostasis|September 1, 1996
Two recombinant tissue factor reagents compared to conventional thromboplastins for determination of international normalised ratio: a thirty-three-laboratory collaborative study. The Steering Committee of the UK National External Quality Assessment Scheme for Blood CoagulationS Kitchen, I Jennings, T A Woods, et al.
Clinical and Laboratory Haematology|January 1, 1986
Co-incidental Von Willebrands disease and immune thrombocytopenia in pregnancy: treatment with high dose intravenous immunoglobulinD Maharaj, I D Walker, H P McEwan, et al.
The Journal of Biological Chemistry|May 25, 1987
Lethal perinatal osteogenesis imperfecta due to the substitution of arginine for glycine at residue 391 of the alpha 1(I) chain of type I collagenJ F Bateman, D Chan, I D Walker, et al.
British Journal of Haematology|February 26, 2000
Prevalence of the post-thrombotic syndrome in young women with previous venous thromboembolismM D McColl, J Ellison, I A Greer, et al.
The Journal of Thoracic and Cardiovascular Surgery|October 1, 1982
Prostacyclin in cardiopulmonary bypass operationsA Faichney, K G Davidson, D J Wheatley, et al.
British Journal of Haematology|June 1, 1993
Reduced coagulation activation following infusion of a highly purified factor IX concentrate compared to a prothrombin complex concentrateK K Hampton, F E Preston, G D Lowe, et al.
Pageof 20